State of Wisconsin Investment Board
VERV

State of Wisconsin Investment Board’s Verve Therapeutics VERV Stock Holding History

State of Wisconsin Investment Board’s Portfolio VERV Stock Details VERV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-22,714
Closed -$111K – 2367
2024
Q2 		$111K Sell
22,714
-957
-4% -$6.01K ﹤0.01% 2219
2024
Q1 		$314K Sell
23,671
-3,985
-14% -$52.8K ﹤0.01% 1944
2023
Q4 		$386K Buy
27,656
+665
+2% +$8.24K ﹤0.01% 1900
2023
Q3 		$358K Buy
26,991
+73
+0.3% +$1.18K ﹤0.01% 1974
2023
Q2 		$505K Sell
26,918
-1,096
-4% -$18.3K ﹤0.01% 1825
2023
Q1 		$404K Sell
28,014
-2,996
-10% -$58.7K ﹤0.01% 1956
2022
Q4 		$600K Sell
31,010
-1,894
-6% -$50.2K ﹤0.01% 1821
2022
Q3 		$1.13M Buy
32,904
+14,257
+76% +$455K ﹤0.01% 1495
2022
Q2 		$285K Sell
18,647
-2,053
-10% -$31.8K ﹤0.01% 2345
2022
Q1 		$472K Hold
20,700
– – ﹤0.01% 1955
2021
Q4 		$763K Buy
+20,700
New +$870K ﹤0.01% 1535

Other funds holding VERV

AI
Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return

State of Wisconsin Investment Board's VERV Position: Q3 2024 in Review

State of Wisconsin Investment Board sold out of Verve Therapeutics (VERV) in Q3 2024, closing a stake of 22,714 shares — an estimated $111K sold.

State of Wisconsin Investment Board first reported a position in VERV in Q4 2021 and held it in 11 quarters. The position peaked at $1.13M in Q3 2022. 174 funds tracked by Wall St. Rank hold VERV as of Q3 2024.

  • State of Wisconsin Investment Board reported no remaining Verve Therapeutics position as of Q3 2024 after selling out during the quarter.
  • State of Wisconsin Investment Board sold 22,714 Verve Therapeutics shares in Q3 2024, an estimated $111K.
  • State of Wisconsin Investment Board first reported a position in Verve Therapeutics in Q4 2021 and held it in 11 quarters.
  • State of Wisconsin Investment Board's Verve Therapeutics position peaked at $1.13M in Q3 2022.
  • 174 funds tracked by Wall St. Rank held Verve Therapeutics as of Q3 2024.

Based on State of Wisconsin Investment Board's 13F filing for Q3 2024, filed 14 Nov 2024.